Pla2g5 Mouse 17alpha-ethynylestradiol affects expression ISO RGD:62051 6480464 Ethinyl Estradiol affects the expression of PLA2G5 mRNA CTD PMID:15212814 Pla2g5 Mouse 17alpha-ethynylestradiol decreases expression ISO RGD:62051 6480464 Ethinyl Estradiol results in decreased expression of PLA2G5 mRNA CTD PMID:17351261 Pla2g5 Mouse 17beta-estradiol multiple interactions ISO RGD:62051 6480464 [bisphenol A co-treated with Estradiol] results in increased expression of PLA2G5 mRNA; [estradiol 3-benzoate co-treated more ... CTD PMID:26496021|PMID:32741896 Pla2g5 Mouse 17beta-estradiol 3-benzoate multiple interactions ISO RGD:62051 6480464 [estradiol 3-benzoate co-treated with [Testosterone co-treated with Estradiol]] results in increased expression of PLA2G5 mRNA CTD PMID:32741896 Pla2g5 Mouse 17beta-hydroxy-5alpha-androstan-3-one increases expression ISO RGD:735328 6480464 Dihydrotestosterone results in increased expression of PLA2G5 mRNA CTD PMID:29581250 Pla2g5 Mouse 2,2',5,5'-tetrachlorobiphenyl increases expression ISO RGD:62051 6480464 2,5,2',5'-tetrachlorobiphenyl results in increased expression of PLA2G5 mRNA CTD PMID:23829299 Pla2g5 Mouse 2,3,7,8-tetrachlorodibenzodioxine increases expression ISO RGD:62051 6480464 Tetrachlorodibenzodioxin results in increased expression of PLA2G5 mRNA CTD PMID:32109520 Pla2g5 Mouse 2,3,7,8-tetrachlorodibenzodioxine decreases expression ISO RGD:62051 6480464 Tetrachlorodibenzodioxin results in decreased expression of PLA2G5 mRNA CTD PMID:33387578 Pla2g5 Mouse 2,3,7,8-tetrachlorodibenzodioxine decreases expression EXP 6480464 Tetrachlorodibenzodioxin results in decreased expression of PLA2G5 mRNA CTD PMID:33956508 Pla2g5 Mouse 2-amino-2-deoxy-D-glucopyranose multiple interactions ISO RGD:62051 6480464 Glucosamine inhibits the reaction [IL1B results in increased expression of PLA2G5 mRNA]; IL1B inhibits the more ... CTD PMID:17109745 Pla2g5 Mouse 2-amino-2-deoxy-D-glucopyranose decreases expression ISO RGD:62051 6480464 Glucosamine results in decreased expression of PLA2G5 mRNA CTD PMID:17109745 Pla2g5 Mouse 5-aza-2'-deoxycytidine multiple interactions ISO RGD:735328 6480464 [Decitabine co-treated with IFNG protein] results in increased expression of PLA2G5 mRNA CTD PMID:18953428 Pla2g5 Mouse 6-propyl-2-thiouracil decreases expression ISO RGD:62051 6480464 Propylthiouracil results in decreased expression of PLA2G5 mRNA CTD PMID:25825206 Pla2g5 Mouse 6-propyl-2-thiouracil multiple interactions EXP 6480464 [Propylthiouracil co-treated with Iodine deficiency] results in decreased expression of PLA2G5 mRNA CTD PMID:36706583 Pla2g5 Mouse aflatoxin B1 increases methylation ISO RGD:735328 6480464 Aflatoxin B1 results in increased methylation of PLA2G5 intron CTD PMID:30157460 Pla2g5 Mouse aldehydo-D-glucosamine multiple interactions ISO RGD:62051 6480464 Glucosamine inhibits the reaction [IL1B results in increased expression of PLA2G5 mRNA]; IL1B inhibits the more ... CTD PMID:17109745 Pla2g5 Mouse aldehydo-D-glucosamine decreases expression ISO RGD:62051 6480464 Glucosamine results in decreased expression of PLA2G5 mRNA CTD PMID:17109745 Pla2g5 Mouse ammonium chloride decreases expression ISO RGD:62051 6480464 Ammonium Chloride results in decreased expression of PLA2G5 protein CTD PMID:16483693 Pla2g5 Mouse ammonium chloride affects expression ISO RGD:62051 6480464 Ammonium Chloride affects the expression of PLA2G5 mRNA CTD PMID:16483693 Pla2g5 Mouse arachidonic acid multiple interactions ISO RGD:735328 6480464 PLA2G5 protein promotes the reaction [N-Formylmethionine Leucyl-Phenylalanine results in increased abundance of Arachidonic Acid] CTD PMID:9495842 Pla2g5 Mouse arsane affects expression ISO RGD:735328 6480464 Arsenic affects the expression of PLA2G5 mRNA CTD PMID:18414638 Pla2g5 Mouse arsenic atom affects expression ISO RGD:735328 6480464 Arsenic affects the expression of PLA2G5 mRNA CTD PMID:18414638 Pla2g5 Mouse atrazine decreases expression ISO RGD:62051 6480464 Atrazine results in decreased expression of PLA2G5 mRNA CTD PMID:36841081 Pla2g5 Mouse benazepril decreases expression ISO RGD:62051 6480464 benazepril results in decreased expression of PLA2G5 mRNA CTD PMID:14871019 Pla2g5 Mouse benzalkonium chloride decreases expression EXP 6480464 Benzalkonium Compounds results in decreased expression of PLA2G5 mRNA CTD PMID:30171875 Pla2g5 Mouse benzo[a]pyrene increases expression EXP 6480464 Benzo(a)pyrene results in increased expression of PLA2G5 mRNA CTD PMID:27195522 Pla2g5 Mouse benzo[a]pyrene increases methylation ISO RGD:735328 6480464 Benzo(a)pyrene results in increased methylation of PLA2G5 3' UTR; Benzo(a)pyrene results in increased methylation of more ... CTD PMID:27901495 Pla2g5 Mouse benzo[e]pyrene increases methylation ISO RGD:735328 6480464 benzo(e)pyrene results in increased methylation of PLA2G5 intron CTD PMID:30157460 Pla2g5 Mouse beta-D-glucosamine multiple interactions ISO RGD:62051 6480464 Glucosamine inhibits the reaction [IL1B results in increased expression of PLA2G5 mRNA]; IL1B inhibits the more ... CTD PMID:17109745 Pla2g5 Mouse beta-D-glucosamine decreases expression ISO RGD:62051 6480464 Glucosamine results in decreased expression of PLA2G5 mRNA CTD PMID:17109745 Pla2g5 Mouse bisphenol A multiple interactions ISO RGD:62051 6480464 [bisphenol A co-treated with Estradiol] results in increased expression of PLA2G5 mRNA CTD PMID:26496021 Pla2g5 Mouse bisphenol A increases expression EXP 6480464 bisphenol A results in increased expression of PLA2G5 mRNA CTD PMID:32156529 Pla2g5 Mouse bisphenol A increases methylation EXP 6480464 bisphenol A results in increased methylation of PLA2G5 promoter CTD PMID:27312807 Pla2g5 Mouse bisphenol A decreases methylation EXP 6480464 bisphenol A results in decreased methylation of PLA2G5 promoter CTD PMID:27312807 Pla2g5 Mouse bisphenol A increases expression ISO RGD:62051 6480464 bisphenol A results in increased expression of PLA2G5 mRNA CTD PMID:25181051 Pla2g5 Mouse bisphenol F decreases expression ISO RGD:62051 6480464 4,4'-bisphenol F results in decreased expression of PLA2G5 mRNA CTD PMID:26186136 Pla2g5 Mouse cadmium atom increases expression ISO RGD:62051 6480464 Cadmium results in increased expression of PLA2G5 mRNA CTD PMID:25808797 Pla2g5 Mouse cadmium dichloride increases expression ISO RGD:735328 6480464 Cadmium Chloride results in increased expression of PLA2G5 mRNA CTD PMID:38568856 Pla2g5 Mouse CGP 52608 multiple interactions ISO RGD:735328 6480464 CGP 52608 promotes the reaction [RORA protein binds to PLA2G5 gene] CTD PMID:28238834 Pla2g5 Mouse choline multiple interactions EXP 6480464 [Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in increased expression more ... CTD PMID:20938992 Pla2g5 Mouse cisplatin increases expression EXP 6480464 Cisplatin results in increased expression of PLA2G5 mRNA CTD PMID:15471895 Pla2g5 Mouse clofibrate multiple interactions EXP 6480464 [Clofibrate co-treated with Acetaminophen] affects the expression of PLA2G5 mRNA; PPARA affects the reaction [[Clofibrate more ... CTD PMID:17585979 Pla2g5 Mouse Cuprizon increases expression ISO RGD:62051 6480464 Cuprizone results in increased expression of PLA2G5 mRNA CTD PMID:26577399 Pla2g5 Mouse dibutyl phthalate decreases expression ISO RGD:62051 6480464 Dibutyl Phthalate results in decreased expression of PLA2G5 mRNA CTD PMID:21266533 Pla2g5 Mouse dibutyl phthalate decreases expression EXP 6480464 Dibutyl Phthalate results in decreased expression of PLA2G5 mRNA CTD PMID:17361019 Pla2g5 Mouse diiodine multiple interactions EXP 6480464 [Propylthiouracil co-treated with Iodine deficiency] results in decreased expression of PLA2G5 mRNA CTD PMID:36706583 Pla2g5 Mouse doxorubicin decreases expression ISO RGD:62051 6480464 Doxorubicin results in decreased expression of PLA2G5 mRNA CTD PMID:19915844 Pla2g5 Mouse doxorubicin decreases expression ISO RGD:735328 6480464 Doxorubicin results in decreased expression of PLA2G5 mRNA CTD PMID:29803840 Pla2g5 Mouse doxorubicin multiple interactions EXP 6480464 [[MT1 protein co-treated with MT2 protein] affects the susceptibility to Doxorubicin] which affects the expression more ... CTD PMID:21040762 Pla2g5 Mouse doxorubicin decreases expression EXP 6480464 Doxorubicin results in decreased expression of PLA2G5 mRNA CTD PMID:21040762 Pla2g5 Mouse enzalutamide decreases expression ISO RGD:735328 6480464 enzalutamide results in decreased expression of PLA2G5 mRNA CTD PMID:29581250 Pla2g5 Mouse epoxiconazole increases expression EXP 6480464 epoxiconazole results in increased expression of PLA2G5 mRNA CTD PMID:35436446 Pla2g5 Mouse ethanol increases expression EXP 6480464 Ethanol results in increased expression of PLA2G5 mRNA CTD PMID:30319688 Pla2g5 Mouse folic acid multiple interactions EXP 6480464 [Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in increased expression more ... CTD PMID:20938992 Pla2g5 Mouse formaldehyde decreases expression ISO RGD:62051 6480464 Formaldehyde results in decreased expression of PLA2G5 mRNA CTD PMID:17285311 Pla2g5 Mouse gentamycin decreases expression ISO RGD:62051 6480464 Gentamicins results in decreased expression of PLA2G5 mRNA CTD PMID:33387578 Pla2g5 Mouse glycidol increases expression ISO RGD:62051 6480464 glycidol results in increased expression of PLA2G5 mRNA CTD PMID:24395379 Pla2g5 Mouse hydrogen peroxide increases expression EXP 6480464 Hydrogen Peroxide results in increased expression of PLA2G5 mRNA CTD PMID:14729362 Pla2g5 Mouse hydrogen peroxide affects expression ISO RGD:735328 6480464 Hydrogen Peroxide affects the expression of PLA2G5 protein CTD PMID:21179406 Pla2g5 Mouse icosanoid multiple interactions EXP 6480464 PLA2G5 protein promotes the reaction [Pam(3)CSK(4) peptide results in increased metabolism of Eicosanoids]; PLA2G5 protein more ... CTD PMID:17369491 Pla2g5 Mouse isoliquiritigenin decreases expression ISO RGD:735328 6480464 isoliquiritigenin results in decreased expression of PLA2G5 mRNA CTD PMID:23747687 Pla2g5 Mouse L-methionine multiple interactions EXP 6480464 [Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in increased expression more ... CTD PMID:20938992 Pla2g5 Mouse lead diacetate affects expression ISO RGD:62051 6480464 lead acetate affects the expression of PLA2G5 mRNA CTD PMID:21864555 Pla2g5 Mouse lead diacetate decreases expression ISO RGD:62051 6480464 lead acetate results in decreased expression of PLA2G5 mRNA CTD PMID:22641619 Pla2g5 Mouse leukotriene C4 multiple interactions ISO RGD:735328 6480464 PLA2G5 protein promotes the reaction [N-Formylmethionine Leucyl-Phenylalanine results in increased abundance of Leukotriene C4] CTD PMID:9495842 Pla2g5 Mouse leukotriene C4 multiple interactions EXP 6480464 PLA2G5 protein promotes the reaction [Zymosan results in increased metabolism of Leukotriene C4] CTD PMID:14761945 Pla2g5 Mouse lipopolysaccharide multiple interactions ISO RGD:735328 6480464 [S-(1,2-dichlorovinyl)cysteine co-treated with Lipopolysaccharides] results in decreased expression of PLA2G5 mRNA CTD PMID:35811015 Pla2g5 Mouse methamphetamine increases expression ISO RGD:735328 6480464 Methamphetamine results in increased expression of PLA2G5 mRNA CTD PMID:25290377 Pla2g5 Mouse methapyrilene increases methylation ISO RGD:735328 6480464 Methapyrilene results in increased methylation of PLA2G5 intron CTD PMID:30157460 Pla2g5 Mouse N-formyl-L-methionyl-L-leucyl-L-phenylalanine increases activity ISO RGD:735328 6480464 N-Formylmethionine Leucyl-Phenylalanine results in increased activity of PLA2G5 protein CTD PMID:11741884 Pla2g5 Mouse N-formyl-L-methionyl-L-leucyl-L-phenylalanine multiple interactions ISO RGD:735328 6480464 PLA2G5 protein promotes the reaction [N-Formylmethionine Leucyl-Phenylalanine results in increased abundance of Arachidonic Acid]; PLA2G5 more ... CTD PMID:9495842 Pla2g5 Mouse N-formyl-L-methionyl-L-leucyl-L-phenylalanine increases secretion ISO RGD:735328 6480464 N-Formylmethionine Leucyl-Phenylalanine results in increased secretion of PLA2G5 protein CTD PMID:11741884 Pla2g5 Mouse N-nitrosodiethylamine multiple interactions EXP 6480464 [Piperonyl Butoxide co-treated with Diethylnitrosamine] affects the methylation of PLA2G5 gene CTD PMID:23968726 Pla2g5 Mouse naphthalene increases expression EXP 6480464 naphthalene results in increased expression of PLA2G5 mRNA CTD PMID:18978301 Pla2g5 Mouse paracetamol multiple interactions EXP 6480464 [Clofibrate co-treated with Acetaminophen] affects the expression of PLA2G5 mRNA; PPARA affects the reaction [[Clofibrate more ... CTD PMID:17585979 Pla2g5 Mouse paracetamol decreases expression ISO RGD:62051 6480464 Acetaminophen results in decreased expression of PLA2G5 mRNA CTD PMID:33387578 Pla2g5 Mouse PCB138 decreases expression ISO RGD:62051 6480464 2,2',3',4,4',5-hexachlorobiphenyl results in decreased expression of PLA2G5 mRNA CTD PMID:23829299 Pla2g5 Mouse pentanal decreases expression ISO RGD:735328 6480464 pentanal results in decreased expression of PLA2G5 mRNA CTD PMID:26079696 Pla2g5 Mouse peptidoglycan multiple interactions EXP 6480464 PLA2G5 protein promotes the reaction [Peptidoglycan results in increased metabolism of Eicosanoids] CTD PMID:17369491 Pla2g5 Mouse piperonyl butoxide multiple interactions EXP 6480464 [Piperonyl Butoxide co-treated with Diethylnitrosamine] affects the methylation of PLA2G5 gene CTD PMID:23968726 Pla2g5 Mouse progesterone increases expression ISO RGD:62051 6480464 Progesterone results in increased expression of PLA2G5 mRNA CTD PMID:20726854 Pla2g5 Mouse progesterone decreases expression EXP 6480464 Progesterone results in decreased expression of PLA2G5 mRNA CTD PMID:22238285 Pla2g5 Mouse propanal decreases expression ISO RGD:735328 6480464 propionaldehyde results in decreased expression of PLA2G5 mRNA CTD PMID:26079696 Pla2g5 Mouse prostaglandin E2 multiple interactions EXP 6480464 PLA2G5 protein promotes the reaction [Zymosan results in increased metabolism of Dinoprostone] CTD PMID:14761945 Pla2g5 Mouse rotenone decreases expression ISO RGD:62051 6480464 Rotenone results in decreased expression of PLA2G5 mRNA CTD PMID:28374803 Pla2g5 Mouse S-(1,2-dichlorovinyl)-L-cysteine multiple interactions ISO RGD:735328 6480464 [S-(1,2-dichlorovinyl)cysteine co-treated with Lipopolysaccharides] results in decreased expression of PLA2G5 mRNA CTD PMID:35811015 Pla2g5 Mouse sarin decreases expression ISO RGD:735328 6480464 Sarin results in decreased expression of PLA2G5 mRNA CTD PMID:19522546 Pla2g5 Mouse sarin increases expression ISO RGD:735328 6480464 Sarin results in increased expression of PLA2G5 mRNA CTD PMID:19522546 Pla2g5 Mouse silicon dioxide increases expression ISO RGD:735328 6480464 Silicon Dioxide analog results in increased expression of PLA2G5 mRNA CTD PMID:25895662 Pla2g5 Mouse tert-butyl hydroperoxide increases expression EXP 6480464 tert-Butylhydroperoxide results in increased expression of PLA2G5 mRNA CTD PMID:14729362|PMID:15336504 Pla2g5 Mouse testosterone multiple interactions ISO RGD:62051 6480464 [estradiol 3-benzoate co-treated with [Testosterone co-treated with Estradiol]] results in increased expression of PLA2G5 mRNA CTD PMID:32741896 Pla2g5 Mouse titanium dioxide decreases expression EXP 6480464 titanium dioxide results in decreased expression of PLA2G5 mRNA CTD PMID:35295148 Pla2g5 Mouse trichloroethene decreases expression ISO RGD:62051 6480464 Trichloroethylene results in decreased expression of PLA2G5 mRNA CTD PMID:33387578 Pla2g5 Mouse trimellitic anhydride affects expression EXP 6480464 trimellitic anhydride affects the expression of PLA2G5 mRNA CTD PMID:19042947